AU2001258754A1 - Aqueous liquid preparation - Google Patents

Aqueous liquid preparation

Info

Publication number
AU2001258754A1
AU2001258754A1 AU2001258754A AU5875401A AU2001258754A1 AU 2001258754 A1 AU2001258754 A1 AU 2001258754A1 AU 2001258754 A AU2001258754 A AU 2001258754A AU 5875401 A AU5875401 A AU 5875401A AU 2001258754 A1 AU2001258754 A1 AU 2001258754A1
Authority
AU
Australia
Prior art keywords
aqueous liquid
liquid preparation
aqueous solution
acceptable salt
pharmacologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258754A
Other languages
English (en)
Inventor
Hisayuki Nakayama
Fukiko Yamasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of AU2001258754A1 publication Critical patent/AU2001258754A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C07D261/16—Benzene-sulfonamido isoxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
AU2001258754A 2000-05-17 2001-05-16 Aqueous liquid preparation Abandoned AU2001258754A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000145640 2000-05-17
JP2000-145640 2000-05-17
PCT/JP2001/004083 WO2001087303A1 (fr) 2000-05-17 2001-05-16 Preparation liquide aqueuse

Publications (1)

Publication Number Publication Date
AU2001258754A1 true AU2001258754A1 (en) 2001-11-26

Family

ID=18652118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258754A Abandoned AU2001258754A1 (en) 2000-05-17 2001-05-16 Aqueous liquid preparation

Country Status (10)

Country Link
EP (1) EP1283042B1 (es)
JP (1) JP4754149B2 (es)
KR (1) KR100776579B1 (es)
CN (1) CN1210028C (es)
AT (1) ATE410164T1 (es)
AU (1) AU2001258754A1 (es)
DE (1) DE60136064D1 (es)
ES (1) ES2310550T3 (es)
PT (1) PT1283042E (es)
WO (1) WO2001087303A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5785353B2 (ja) * 2004-02-27 2015-09-30 大正製薬株式会社 眼科用剤
JP2005247803A (ja) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd 点眼剤及びその容器
JP2005247801A (ja) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd 安定な点眼剤
JP4845405B2 (ja) * 2004-03-29 2011-12-28 ロート製薬株式会社 プラノプロフェン含有医薬製剤
JP5623684B2 (ja) * 2006-10-13 2014-11-12 ゼリア新薬工業株式会社 眼科用剤
JP6009141B2 (ja) * 2009-10-09 2016-10-19 ロート製薬株式会社 水性組成物
JP5992293B2 (ja) * 2012-10-31 2016-09-14 大正製薬株式会社 眼科用剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
JPH05186349A (ja) * 1991-12-30 1993-07-27 Teika Seiyaku Kk プラノプロフェン点眼剤組成物
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
JPH10236951A (ja) * 1996-12-27 1998-09-08 Teika Seiyaku Kk プラノプロフェン配合点眼剤
JPH10295777A (ja) * 1997-04-28 1998-11-10 Taisho Pharmaceut Co Ltd 安定な抗菌点眼剤

Also Published As

Publication number Publication date
CN1438887A (zh) 2003-08-27
EP1283042A1 (en) 2003-02-12
CN1210028C (zh) 2005-07-13
DE60136064D1 (de) 2008-11-20
ES2310550T3 (es) 2009-01-16
ATE410164T1 (de) 2008-10-15
JP4754149B2 (ja) 2011-08-24
WO2001087303A1 (fr) 2001-11-22
KR20020094052A (ko) 2002-12-16
EP1283042B1 (en) 2008-10-08
KR100776579B1 (ko) 2007-11-15
EP1283042A4 (en) 2007-05-23
PT1283042E (pt) 2008-11-19

Similar Documents

Publication Publication Date Title
NO20034149L (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
CY1107841T1 (el) Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας
HK1083596A1 (en) Intranasal formulation of rotigotine
IL231675A0 (en) Concentrated protein compositions with reduced viscosity
DE69932313D1 (de) Wässerige flüssige zubereitungen
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
WO2002100914A3 (en) Polymeric material, containing a latent acid
CA2406849A1 (en) Stabilized liquid preparation
AU2001258754A1 (en) Aqueous liquid preparation
EP1426360A4 (en) 2-PHENYL-3-HETEROARYLPROPIONIC ACID DERIVATIVE OR SALT THEREOF AND MEDICAMENTS CONTAINING THE SAME
BR0112258A (pt) Sistema de entrega de droga para drogas pouco solúveis em água
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
ZA200305877B (en) Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof.
EA200101150A1 (ru) Раствор прукалоприда для перорального применения
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
ZA200203078B (en) Ciclesonide-containing aqueous pharmaceutical composition.
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
SE9902742D0 (sv) New pharmaceutical formultion
AU2003268706A1 (en) PROCESS FOR PRODUCING OPTICALLY ACTIVE Alpha-SUBSTITUTED CYSTEINE OR SALT THEREOF, INTERMEDIATE THEREFOR, AND PROCESS FOR PRODUCING THE SAME
MXPA03000664A (es) Derivados n-sustituidos del acido 1-amino-1, 1-dialquilcarboxilico.
AP2003002897A0 (en) Processes and intermediates for preparing benzyl epoxides
HN2004000123A (es) Composición agroquimica en suspensión acuosa
AU3183101A (en) Stable aqueous deoxyfructosazine solution
ITLI990012U1 (it) Strumento per la decifrazione dei messaggi in codice.
AU2002322433A1 (en) N,n-dinitramide salts as solubilizing agents for biologically active agents